ASP Isotopes Inc.

ASP Isotopes Inc. (ASPI) priced its initial public offering on Nov 14, 2022 at $4.00 per share, raising $5M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $125.4M. Revere was lead-left underwriter. Hamilton & Associates and Law Group advised the company and Carmel, Milazzo & Feil advised the underwriters.

ASP Isotopes Inc. is a pre-commercial advanced materials company developing technology to produce isotopes for several industries, using an exclusively licensed Aerodynamic Separation Process from Klydon. Its initial focus includes medical radioisotopes and high-assay low-enriched uranium (HALEU).

Status

IPO

Ticker

ASPI

Exchange

Nasdaq Capital Market

Priced

Nov 14, 2022

IPO price

$4.00

Raised

$5M

Market cap at IPO price

$125.4M

First filed

Sep 12, 2022

Underwriters

Revere

Company counsel

Hamilton & Associates and Law Group

Underwriters' counsel

Carmel, Milazzo & Feil

Sector

Industrials & materials

Country / state

TX

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.